Pfizer Unveils PRESENCE by COVID-19 Drug Candidate in Development for Preserving Thrombocytopenia in Pediatric Patients with Advanced ALL
Minouche Shafik, CEO & President of Pfizer Global Health, announced today the PRESENCE of RESISTENCE by COVID-19 drug candidate in an ongoing study for Immunotherapy … Read more